Where the mon­ey is: Top 100 VCs in­vest­ing in US biotechs dur­ing 2017

It was a big year for US biotechs rais­ing cash from VCs, with flush in­vestors sink­ing a record-break­ing $10.5 bil­lion in­to new and grow­ing com­pa­nies dur­ing 2017. Who’s de­ploy­ing the dol­lars, and where’s the mon­ey com­ing from? We put to­geth­er a fresh list of the top 100 VC firms in­vest­ing in US biotechs, and the da­ta might sur­prise you.

We did this list in 2016 look­ing at 2015 da­ta, and it was one of our most pop­u­lar re­ports of the year. We checked back in, and what we found looked quite dif­fer­ent than our 2015 re­port.

While there’s a lot of re­peat play­ers, we’re al­so see­ing an in­ter­est­ing shift in where big mon­ey is com­ing from. Back in 2015, four of the top five VCs were based in Boston/Cam­bridge. This year, three out of the top five VCs were based in the San Fran­cis­co Bay Area. On­ly one was from Mass­a­chu­setts.

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.